IL278906A - Compositions and methods for treating steroid hormone-related diseases or disorders - Google Patents

Compositions and methods for treating steroid hormone-related diseases or disorders

Info

Publication number
IL278906A
IL278906A IL278906A IL27890620A IL278906A IL 278906 A IL278906 A IL 278906A IL 278906 A IL278906 A IL 278906A IL 27890620 A IL27890620 A IL 27890620A IL 278906 A IL278906 A IL 278906A
Authority
IL
Israel
Prior art keywords
disorders
compositions
methods
related diseases
steroid hormone
Prior art date
Application number
IL278906A
Other languages
Hebrew (he)
Other versions
IL278906B1 (en
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of IL278906A publication Critical patent/IL278906A/en
Publication of IL278906B1 publication Critical patent/IL278906B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL278906A 2018-06-01 2019-05-30 Compositions and methods for treating steroid hormone-related diseases or disorders IL278906B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862679386P 2018-06-01 2018-06-01
PCT/US2019/034548 WO2019232146A1 (en) 2018-06-01 2019-05-30 Compositions and methods for treating steroid hormone-related diseases or disorders

Publications (2)

Publication Number Publication Date
IL278906A true IL278906A (en) 2021-01-31
IL278906B1 IL278906B1 (en) 2024-04-01

Family

ID=68698983

Family Applications (1)

Application Number Title Priority Date Filing Date
IL278906A IL278906B1 (en) 2018-06-01 2019-05-30 Compositions and methods for treating steroid hormone-related diseases or disorders

Country Status (11)

Country Link
US (1) US20210196779A1 (en)
EP (1) EP3801483A4 (en)
JP (1) JP7433249B2 (en)
KR (1) KR20210033947A (en)
CN (1) CN112437660A (en)
AU (1) AU2019278986A1 (en)
CA (1) CA3101194A1 (en)
IL (1) IL278906B1 (en)
SG (1) SG11202011521RA (en)
TW (1) TW202042833A (en)
WO (1) WO2019232146A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202011521RA (en) 2018-06-01 2020-12-30 Univ Yale Compositions and methods for treating steroid hormone-related diseases or disorders
KR20230005187A (en) * 2020-03-30 2023-01-09 예일 유니버시티 Methods for Treating Inflammatory and Fibrous Diseases and Disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10139639A (en) * 1996-11-07 1998-05-26 Kao Corp Hair growth-inhibiting agent
US20030099725A1 (en) * 2001-02-26 2003-05-29 Global Cancer Strategies Ltd. Herbal compositions useful as chemopreventive and therapeutic agents and methods of manufacturing same
GB0317020D0 (en) * 2003-07-21 2003-08-27 Sahajanand Biotech Private Ltd Herbo-mineral formulation for refractory leukemias and lymphomas
MX2007010603A (en) * 2005-03-23 2007-10-18 Pfizer Prod Inc Therapy of prostate cancer with ctla4 antibodies and hormonal therapy.
KR100997912B1 (en) * 2008-06-27 2010-12-03 한국 한의학 연구원 Compositions and functional food for prevention and treatment of diabetic complications
US9238051B2 (en) * 2010-05-10 2016-01-19 The Florida International University Board Of Trustees Plant-derived formulations for treatment of HIV
CA2804127A1 (en) * 2010-07-07 2012-01-12 Green Peptide Co., Ltd. Cancer peptide vaccine
KR20120092280A (en) * 2011-02-11 2012-08-21 주식회사한국전통의학연구소 Composition for treatment of brain cancers and beauty expenses composition comprising extract of rubiae radix
CN102210768A (en) * 2011-05-15 2011-10-12 宋修刚 Traditional Chinese medicine for treating prostatic cancer
EP2771688B1 (en) * 2011-10-25 2018-09-26 Memorial Sloan-Kettering Cancer Center Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer
US20150297652A1 (en) * 2012-11-20 2015-10-22 Vita Naturale, Llc Compositions and methods for their dermatological use
KR101322661B1 (en) 2013-03-12 2013-10-30 충남대학교산학협력단 A composition comprising mollugin for treating or preventing breast and ovary cancer
CN103550237B (en) * 2013-11-11 2017-05-17 南京中医药大学 Composition of active ingredients of rubia cordifolia as well as application of composition in medicines
CN105878163A (en) * 2016-06-03 2016-08-24 史春艳 Cleansing salt and preparing method thereof
SG11202011521RA (en) 2018-06-01 2020-12-30 Univ Yale Compositions and methods for treating steroid hormone-related diseases or disorders

Also Published As

Publication number Publication date
CA3101194A1 (en) 2019-12-05
IL278906B1 (en) 2024-04-01
JP2021526527A (en) 2021-10-07
US20210196779A1 (en) 2021-07-01
AU2019278986A1 (en) 2020-12-10
SG11202011521RA (en) 2020-12-30
KR20210033947A (en) 2021-03-29
WO2019232146A1 (en) 2019-12-05
JP7433249B2 (en) 2024-02-19
TW202042833A (en) 2020-12-01
EP3801483A4 (en) 2022-03-09
CN112437660A (en) 2021-03-02
EP3801483A1 (en) 2021-04-14

Similar Documents

Publication Publication Date Title
IL280710A (en) Methods and compositions for treating mitochondrial disease or disorders and heteroplasmy
EP3675882A4 (en) Methods and compositions for treatment of microbiome-associated disorders
IL298690B1 (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
EP3746135A4 (en) Methods and compounds for treating disorders
IL269174A (en) Methods for treating complement-mediated diseases and disorders
AU2018297285A1 (en) Compositions and methods for treating or preventing endocrine FGF-linked diseases
EP3826666A4 (en) Compositions and methods for treating nrp2-associated diseases
EP3681477A4 (en) Method of and improved composition for treating triterpene-responsive conditions, diseases or disorders
EP3507371A4 (en) Methods and compositions for treating diseases and disorders of the nervous system
EP3703706A4 (en) Compositions for and method of treating acid-base disorders
EP3589283A4 (en) Method and composition for treating eating disorders
EP3609525A4 (en) Compositions and methods for treating or preventing gut permeability-related disorders
IL270114B1 (en) Methods and compositions for treating neurological disorders
ZA202100703B (en) Compositions and methods for treating inflammasome related diseases or conditions
EP3902536A4 (en) Compositions and methods for treating neurodegenerative disorders
IL275985A (en) Compositions and methods for treating retinal disorders
SG11202011151VA (en) Compositions and methods for reducing spliceopathy and treating rna dominance disorders
ZA202002991B (en) Methods and compositions for assessing and treating intraocular diseases and disorders
IL278906A (en) Compositions and methods for treating steroid hormone-related diseases or disorders
EP3829587A4 (en) Compositions and methods for treating brain-gut disorders
PL3810128T3 (en) Compositions for treating and/or preventing protein-aggregation diseases
EP3735129A4 (en) Compositions and methods for treating neurological and other disorders
IL292186A (en) Compositions and methods for treating blood disorders
EP3672583A4 (en) Compositions and methods for treating neurodegenerative diseases
IL286571A (en) Compositions and methods for treating neurodegenerative disorders